14.4 MOUNJARO Use in Combination with Basal Insulin with or without Metformin in Adult Patients with Type 2 Diabetes Mellitus SURPASS-5 (NCT04039503) was a 40-week double-blind trial that randomized 475 adult patients with type 2 diabetes mellitus with inadequate glycemic control on insulin glargine 100 units/mL, with or without metformin, to subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, MOUNJARO 15 mg once weekly, or placebo
There are group types like working moms, or people that travel for work so you can all share tips based on similar situations
If you arent able to eat a meal, you shouldnt take your dose of glipizide
Liraglutide Liraglutide is another FDA-approved GLP-1 receptor agonist, available only as a daily injection and under the brand names Victoza and Saxenda
He died on the same day as Howard Staunton, incidentally also on Paul Morphy's birthday, June 22, in 1987
Slower dose titration may reduce side effects